FDA Inspection 570583 — Shire Human Genetic Therapies, Inc.

Shire Human Genetic Therapies, Inc. — FEI 3009340644

The FDA completed an inspection of Shire Human Genetic Therapies, Inc. on Mar 5, 2009 in Lexington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 5, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.